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Relapse of multiresistant Salmonella typhi after combined therapy
with ciproﬂoxacin and ceftriaxone
Quinolones have become ﬁrst-line drugs as empirical treatment
of enteric fever in endemic areas as well as in low-incidence
countries, leaving third-generation cephalosporins as a par-
enteral alternative [1]. Several cases and outbreaks of quinolone-
resistant Salmonella typhi have been reported, and in vitro sus-
ceptible S. typhi strains have turned out to be clinically resistant
[2,3]. A recent report has suggested that quinolone resistance
in Enterobacteriaceae might be plasmid transferred [4]. This
raises the need for new low-cost orally administered anti-
microbial agents against multiresistant S. typhi (MRDST) and
other Enterobacteriaceae.
We present a case of treatment failure of a MRDST after
combined treatment with a quinolone and a third-generation
cephalosporin and discuss the in vitro resistance pattern in
relation to clinical outcome.
An 8-year-old girl of Pakistani origin was admitted to our
hospital 2 weeks after returning from Pakistan. She presented
with fever (40.4°C), headache, nausea, vomiting, constipation
and abdominal cramps. A blood culture grew S. typhi on the
third day, and she was given intravenous ciproﬂoxacin 200mg
twice daily. Her clinical condition did not improve – she
developed severe diarrhea (×20 stools/day) – and on the 5th
day of treatment, ciproﬂoxacin was increased to 200mg three
times daily and ceftriaxone 100mg/kg once daily was added.
An ultrasonic abdominal scan revealed no abnormalities. Over
the following days her condition improved gradually. After
7 days of treatment, S. typhi could no longer be grown from
blood cultures. She was discharged clinically well after having
received 10 days’ treatment of both ciproﬂoxacin and ceftri-
axone.
Nineteen days after discharge she presented with similar
symptoms. S. typhi with the same susceptibility pattern grew in
blood cultures, and she was given oral ciproﬂoxacin 250mg
twice daily plus intravenous ceftriaxone 100mg/kg/once daily
for 21 days. She recovered during treatment, and no signs of
relapse have been observed after 4 months of follow-up. At no
time during or after any of her hospital stays was S. typhi grown
from her feces. Routine fecal samples of all household members
revealed no carriers.
Susceptibility testing, using tablet diffusion on blood isolates
from both episodes, showed resistance against nalidixic acid
but not against ciproﬂoxacin and ceftriaxone. No increase was
observed in minimal inhibitory concetration (MIC) values dur-
ing treatment. The results of susceptibility testing are displayed
in Table 1. The quinolone MICs show low-level resistance,
below the conventional breakpoint.
The drug of choice for the empirical treatment of S. typhi is
ciproﬂoxacin, but reports from South East Asia and the Indian
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Table 1 Susceptibility pattern of S. typhi isolate(s)
Sensitivity
Antimicrobial agent (table diffusion)a,b MICc (mg/L)
Ampicillin R
Mecillinam S
Cefuroxime S
Ceftriaxone S
Ceftazidime S
Colistin S
Chloramphenicol R
Sulfonamides R
Trimethoprim R
Co-trimoxazole R
Gentamicin S
Netilmicin S
Tobramycin S
Nalidixic acid R
Ciproﬂoxacin S 0.19d
Grepaﬂoxacin S 0.19d
Trovaﬂoxacin Not performed 0.19d
aS, susceptible; R, resistant; bagar diffusion (Rosco Neosensitabs R
on Danish blood agar); cE test; dperformed on primary isolate from
blood culture.
subcontinent raise concern that quinolone-resistant S. typhi is
becoming an increasing problem [3,5]. Slow progression in
clinical condition and/or in vitro resistance to nalidixic acid
should result in the determination of quinolone MIC. S. typhi
with low-level resistance to quinolones may be treated with a
long course of combined quinolone and cephalosporin (third
generation), but close clinical and microbiological evaluation
seems necessary.
Tablet-diffusion susceptibility testing with quinolones is not
reliable for this type of S. typhi because the MIC breakpoint of
1mg/L does not correlate with clinical outcome. Threlfall et al
have suggested a breakpoint of 0.125mg/L [3]. Using nalidixic
acid (tablet diffusion) as a screening tool followed by quinolone
MIC for nalidixic acid-resistant strains may be an equally safe
and cheaper alternative [3].
The new quinolones grepaﬂoxacin and trovaﬂoxacin do not
seem to be alternatives for the treatment of MDRST.
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Pneumococcal psoas abscess: report of two cases
Primary psoas abscess occurs after direct inoculation or hem-
atogenous spread from distant foci, whereas secondary psoas
abscess occurs when infection follows dissemination from an
adjacent structure, mainly bone and genitourinary or intestinal
tracts. Intestinal microorganisms are the major causative agents
of secondary psoas abscesses, whereas Staphylococcus aureus
accounts for more than 80% of primary cases [1].
Primary psoas abscess is less frequent than secondary cases,
and agents other than Staphylococus aureus are rare. A literature
review revealed only 10 cases of Streptococcus pneumoniae primary
psoas abscess [2].We report here two additional cases, diagnosed
in our hospital in March 1998.
A 62-year-old woman presented to the emergency room
with a 6-week history of fever. She had malaise, anorexia, chills
and nocturnal fever, sweating, as well as pain in the lower left
abdominal quadrant, ﬂank and buttock. There was no recent
history of trauma.
On admission the patient had a temperature of 39°C. Physi-
cal examination was unremarkable except for tenderness over
the left ﬂank, without local erythema, swelling or warmth. The
abdomen was soft and non-tender, and there was no evidence
of an abdominal mass on deep palpation. Normal bowel noises
were heard.
Laboratory studies showed a white blood cell count of
8.4× 103/mL (71% polymorphonuclear neutrophils), and
11.2 g/dL of hemoglobin. Erythrocyte sedimentation rate and
ﬁbrinogen were increased, with values of 94mm/h and
900mg/dL, respectively. A conventional serum biochemistry
study revealed no additional relevant information. Urine cul-
ture and two blood culture sets obtained on admission were
negative. Quantitative determinations of immunoglobulin, C3
and C4 serum levels were normal. Total serum hemolytic
complement activity was low (98 mg/mL). Rheumatoid factor,
and antinuclear and anticytoplasmic antibodies, were negative.
A further evaluation by abdominal CT showed a hypodense
ﬂuid collection, suggestive of abscess, in the left psoas muscle,
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with rejection of the renal pelvis. The spine and discal space
were spared. Minimal, purulent material was obtained by CT-
guided aspiration. Gram staining of the purulent material
revealed many polymorphonuclear leukocytes and Gram-posi-
tive cocci in chains. Intravenous meropenem (1 g three times a
day) was initiated. Culture of the purulent ﬂuid yielded a peni-
cillin-susceptible Streptococcus pneumoniae strain. No additional
ﬂuid was obtained after two aspiration attempts.
Seventy-two hours after starting antibiotic therapy, the pati-
ent became afebrile and the ﬂank pain decreased. The pain had
completely resolved by the 10th hospital day. A repeat CT scan
on the 14th day showed partial resolution of the psoas abscess.
At this time, parenteral meropenem was changed to oral cef-
uroxime (1 g three times a day), and the patient was discharged
with good health status. After a 4-week regimen, therapy was
withdrawn, and she was followed as an outpatient, remaining
asymptomatic. A control CT showed a total resolution of the
abscess, with minimal blurring in the muscle as the only residual
manifestation.
A 64-year-old man presented to the emergency room with
pain over the medial region of the left thigh which radiated to
the inguinal region. On physical examination with the leg in
ﬂexion and after adduction of the left hip, an increase in focal
temperature on palpation was noted. The patient had a history
of an upper respiratory infection 15 days prior to admission. No
history of trauma in the previous year was elicited.
On admission, hematologic analysis revealed 13 600 leu-
kocytes/mL (85% polymorphonuclear neutrophils), and
13.3 g/dL of hemoglobin. No remarkable ﬁndings in the con-
ventional serum biochemical analysis were observed. An
abdominal CT revealed a hypodense ﬂuid collection, suggestive
of an abscess in the left psoas muscle that extended into the left
inguinal region. Drainage of the purulent ﬂuid was performed
and empirical antibiotic therapy with metronidazole and tob-
ramycin was initiated. A slow clinical improvement followed
this procedure. The ﬁrst bacterial culture after the CT-guided
aspiration of the purulent material was negative. The second,
performed 12 days later, yielded a penicillin-resistant, cefot-
axime-susceptible Streptococcus pneumoniae isolate. Cultures for
anaerobes were negative. Empirical therapy was then changed
to cefotaxime, due to the intrinsic resistance of Streptococcus
pneumoniae to metronidazole and aminoglycosides. Ultimately,
27 days after drainage was initiated, the abscess had resolved and
the patient was discharged symptomless.
Pneumococcal soft tissue infections, including cellulitis and
muscle infections, are an uncommon condition usually associ-
ated with predisposing factors [3,4].
Staphylococcus aureus is the causative agent in more than 80%
of primary psoas abscesses, a percentage similar to that found
in pyogenic abscesses from other body sites. Infection mainly
originates through hematogenous spread, as described for par-
enteral drug abusers [5], or direct inoculation after trauma. In
